Clinical Trial Update: Phase I Perifosine and Gemcitabine Study [Phase 1]

View source ↗

Summary

Phase I trial of perifosine in combination with gemcitabine in patients with neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Neoplasms | Phase 1 | Status: COMPLETED